← All trials
NCT04065399
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2019
- Primary completion
- Jul 1, 2022
- Completion date
- Jan 1, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 132
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Syndax PharmaceuticalsLead sponsor
- Syndax PharmaceuticalsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.